{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:54:29Z","timestamp":1787061269275,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T00:00:00Z","timestamp":1519430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40261-018-0631-7","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T06:14:03Z","timestamp":1519452843000},"page":"503-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Safety of Intravenous Diltiazem in Reduced Ejection Fraction Heart Failure with Rapid Atrial Fibrillation"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0842-2609","authenticated-orcid":false,"given":"Mohamad Badr","family":"Jandali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,24]]},"reference":[{"issue":"1","key":"631_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0002-9149(99)80525-6","volume":"75","author":"KA Ellenbogen","year":"1995","unstructured":"Ellenbogen KA, et al. Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter. Am J Cardiol. 1995;75(1):45\u20139.","journal-title":"Am J Cardiol"},{"issue":"4","key":"631_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/0735-1097(91)90743-S","volume":"18","author":"KA Ellenbogen","year":"1991","unstructured":"Ellenbogen KA, et al. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study. J Am Coll Cardiol. 1991;18(4):891\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"631_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/0002-9149(89)90076-3","volume":"63","author":"DM Salerno","year":"1989","unstructured":"Salerno DM, et al. Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation\/Flutter Study Group. Am J Cardiol. 1989;63(15):1046\u201351.","journal-title":"Am J Cardiol"},{"issue":"2","key":"631_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0735-1097(00)01107-4","volume":"37","author":"SS Chugh","year":"2001","unstructured":"Chugh SS, et al. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37(2):371\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"6A","key":"631_CR5","doi-asserted-by":"publisher","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","volume":"91","author":"WH Maisel","year":"2003","unstructured":"Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91(6A):2D\u20138D.","journal-title":"Am J Cardiol"},{"issue":"1","key":"631_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/CIRCEP.114.002292","volume":"8","author":"JV Freeman","year":"2015","unstructured":"Freeman JV, et al. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol. 2015;8(1):49\u201358.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"20","key":"631_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/eurheartj\/ehs348","volume":"34","author":"MG Whitbeck","year":"2013","unstructured":"Whitbeck MG, et al. Increased mortality among patients taking digoxin\u2013analysis from the AFFIRM study. Eur Heart J. 2013;34(20):1481\u20138.","journal-title":"Eur Heart J"},{"issue":"10","key":"631_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00228-007-0346-9","volume":"63","author":"P Hallberg","year":"2007","unstructured":"Hallberg P, et al. Digoxin and mortality in atrial fibrillation: a prospective cohort study. Eur J Clin Pharmacol. 2007;63(10):959\u201371.","journal-title":"Eur J Clin Pharmacol"},{"issue":"15","key":"631_CR9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/0002-9149(90)91013-V","volume":"65","author":"M Bohm","year":"1990","unstructured":"Bohm M, Schwinger RH, Erdmann E. Different cardiodepressant potency of various calcium antagonists in human myocardium. Am J Cardiol. 1990;65(15):1039\u201341.","journal-title":"Am J Cardiol"},{"issue":"4","key":"631_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/hrt.45.4.457","volume":"45","author":"PI Joshi","year":"1981","unstructured":"Joshi PI, et al. Nifedipine and left ventricular function in beta-blocked patients. Br Heart J. 1981;45(4):457\u20139.","journal-title":"Br Heart J"},{"issue":"4","key":"631_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.CIR.65.4.660","volume":"65","author":"M Packer","year":"1982","unstructured":"Packer M, et al. Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man. Circulation. 1982;65(4):660\u20138.","journal-title":"Circulation"},{"issue":"4","key":"631_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/01.CIR.65.4.653","volume":"65","author":"J Kieval","year":"1982","unstructured":"Kieval J, et al. The effects of intravenous verapamil on hemodynamic status of patients with coronary artery disease receiving propranolol. Circulation. 1982;65(4):653\u20139.","journal-title":"Circulation"},{"issue":"23","key":"631_CR13","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1161\/CIR.0000000000000041","volume":"130","author":"CT January","year":"2014","unstructured":"January CT, et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):e199\u2013267.","journal-title":"Circulation"},{"issue":"1","key":"631_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","volume":"83","author":"RE Goldstein","year":"1991","unstructured":"Goldstein RE, et al. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. Circulation. 1991;83(1):52\u201360.","journal-title":"Circulation"},{"issue":"3","key":"631_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.CIR.94.3.346","volume":"94","author":"HR Figulla","year":"1996","unstructured":"Figulla HR, et al. Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy. Results of the Diltiazem in Dilated Cardiomyopathy Trial. Circulation. 1996;94(3):346\u201352.","journal-title":"Circulation"},{"key":"631_CR16","doi-asserted-by":"crossref","unstructured":"Moss AJ, et al. The effect of diltiazem on mortality and reinfarction after myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group. N Engl J Med. 1988; 319(7):385\u201392.","DOI":"10.1056\/NEJM198808183190701"},{"issue":"9","key":"631_CR17","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/0002-9149(94)90580-0","volume":"74","author":"IF Goldenberg","year":"1994","unstructured":"Goldenberg IF, et al. Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure. Am J Cardiol. 1994;74(9):884\u20139.","journal-title":"Am J Cardiol"},{"issue":"4","key":"631_CR18","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S0735-1097(84)80365-4","volume":"3","author":"RW Walsh","year":"1984","unstructured":"Walsh RW, et al. Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure. J Am Coll Cardiol. 1984;3(4):1044\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"631_CR19","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","volume":"29","author":"G Delle Karth","year":"2001","unstructured":"Delle Karth G, et al. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med. 2001;29(6):1149\u201353.","journal-title":"Crit Care Med"},{"issue":"13","key":"631_CR20","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/0002-9149(91)90885-O","volume":"67","author":"JT Heywood","year":"1991","unstructured":"Heywood JT, et al. Effects of intravenous diltiazem on rapid atrial fibrillation accompanied by congestive heart failure. Am J Cardiol. 1991;67(13):1150\u20132.","journal-title":"Am J Cardiol"},{"issue":"12","key":"631_CR21","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/0002-9149(87)90862-9","volume":"59","author":"DL Kulick","year":"1987","unstructured":"Kulick DL, et al. Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failure. Am J Cardiol. 1987;59(12):1138\u201343.","journal-title":"Am J Cardiol"},{"issue":"4","key":"631_CR22","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u201384.","journal-title":"Nephron Clin Pract"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-018-0631-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T17:21:44Z","timestamp":1660497704000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-018-0631-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,24]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1007\/s40261-018-0631-7","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,24]]},"assertion":[{"value":"24 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Institutional Review Board approved this project before the start of any data gathering.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The author declares no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}